Injection-Site Reactions Soreness or tenderness at the injection site, typically lasting a few hours to a day Minor redness or swelling that usually resolves within 24 hours Slight bruising , more common if the client is taking blood thinners or supplements like fish oil Mild itching around the injection area, which is generally transient These are common responses to any subcutaneous injection, not reactions specific to lipotropic formulas
AOD 9604 is an unlicensed synthetic hGH peptide fragment with limited human trial data, while retatrutide is an investigational triple incretin receptor agonist
However, for specific, stubborn injuries or in advanced research protocols, some investigators do opt for a localized approach
For those weighing retatrutide against other options, the semaglutide vs tirzepatide comparison provides useful context, as does the retatrutide vs tirzepatide dosage chart for side-by-side dose analysis
Semaglutide -related nausea typically peaks 24 to 48 hours after injection and gradually improves over the following days
This may be too dilute for typical protocols